| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. | N Engl J Med | 2014 | 7.64 |
| 2 | Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. | Sci Transl Med | 2012 | 3.29 |
| 3 | Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells. | Sci Transl Med | 2013 | 2.07 |
| 4 | Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV. | Blood | 2012 | 1.64 |
| 5 | Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? | Mol Ther | 2012 | 0.94 |